World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
74
Citations
30756
World Ranking
19279
National Ranking
648

Eva Comperat publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Eva Comperat sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 454 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Eva Comperat D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Eva Comperat sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 74 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Eva Comperat is affiliated with Sorbonne University in France and has contributed extensively to the field of medicine, with a particular focus on surgery, oncology, pulmonary and respiratory medicine, molecular biology, and urology. Their research portfolio includes a significant number of publications related to bladder and urothelial cancer treatments, urinary and genital oncology studies, prostate cancer diagnosis and treatment, urological disorders and treatments, prostate cancer treatment and research, renal cell carcinoma treatment, and urologic and reproductive health conditions.

The scientist's recent publications reflect involvement in prominent guidelines and classification updates within urology and oncology. Notable papers include:

  • European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines (2020, European Urology)
  • European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ) (2021, European Urology)
  • European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update (2020, European Urology)
  • The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours (2022, European Urology)
  • European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines (2023, European Urology)

Eva Comperat frequently publishes in the following venues:

  • European Urology
  • European Urology Oncology
  • Histopathology
  • The Journal of Urology
  • World Journal of Urology

Their main fields of study focus on medicine, supported by subfields including surgery, pulmonary and respiratory medicine, oncology, molecular biology, and urology. Research topics are specialized around:

  • Bladder and urothelial cancer treatments
  • Urinary and genital oncology studies
  • Prostate cancer diagnosis and treatment
  • Urological disorders and treatments
  • Prostate cancer treatment and research
  • Renal cell carcinoma treatment
  • Urologic and reproductive health conditions

Eva Comperat collaborates regularly with several frequent co-authors in their research field. Among these are:

  • Shahrokh F. Shariat
  • Morgan Rouprêt
  • Olivier Cussenot
  • Benjamin Pradère
  • Mahul B. Amin

Best Publications

  • EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

    Marko Babjuk;Andreas Böhle;Maximilian Burger;Otakar Capoun

  • Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

    J. Alfred Witjes;Thierry Lebret;Eva M. Compérat;Nigel C. Cowan

  • EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

    Marko Babjuk;Maximilian Burger;Richard Zigeuner;Shahrokh F. Shariat

  • European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

    Morgan Rouprêt;Marko Babjuk;Eva Compérat;Richard Zigeuner

  • EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines

    J. Alfred Witjes;Eva Compérat;Nigel C. Cowan;Maria De Santis

  • European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.

    Marko Babjuk;Marko Babjuk;Maximilian Burger;Eva M. Compérat;Paolo Gontero

  • European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).

    Marko Babjuk;Marko Babjuk;Maximilian Burger;Otakar Capoun;Daniel Cohen

  • EAU Guidelines on Penile Cancer: 2014 Update

    Oliver W. Hakenberg;Eva M. Compérat;Suks Minhas;Andrea Necchi

  • European guidelines on upper tract urothelial carcinomas: 2013 update.

    Morgan Rouprêt;Marko Babjuk;Eva Compérat;Richard Zigeuner

  • Prostate Cancer Diagnosis: Multiparametric MR-targeted Biopsy with Cognitive and Transrectal US–MR Fusion Guidance versus Systematic Biopsy—Prospective Multicenter Study

    Philippe Puech;Olivier Rouvière;Raphaele Renard-Penna;Arnauld Villers

  • Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel

    Thomas Seisen;Benoit Peyronnet;Jose Luis Dominguez-Escrig;Harman M. Bruins

  • A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma

    Thomas Seisen;Benjamin Granger;Pierre Colin;Priscilla Léon

  • Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.

    Philippe Camparo;Viorel Vasiliu;Vincent Molinie;Jerome Couturier

  • European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel.

    Richard J. Sylvester;Oscar Rodríguez;Virginia Hernández;Diana Turturica

  • Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review

    Viktor Soukup;Otakar Čapoun;Daniel Cohen;Virginia Hernández

  • Splenic metastases: clinicopathologic presentation, differential diagnosis, and pathogenesis.

    Eva Compérat;Armelle Bardier-Dupas;Philippe Camparo;Frédérique Capron

  • Long-Term Outcomes After Nephron Sparing Surgery for Renal Cell Carcinoma Larger Than 4 cm

    Matthieu Peycelon;Vincent Hupertan;Eva Comperat;Raphaële Renard-Penna

  • Upper Urinary Tract Urothelial Cell Carcinomas and Other Urological Malignancies Involved in the Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) Tumor Spectrum

    Morgan Rouprêt;David R. Yates;Eva Comperat;Olivier Cussenot

  • Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.

    Kiril Trpkov;Ondrej Hes;Abbas Agaimy;Michael Bonert

  • Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old.

    Eva Compérat;Stéphane Larré;Morgan Roupret;Yann Neuzillet

Frequent Co-Authors

Morgan Rouprêt
Morgan Rouprêt Université Paris Cité
Olivier Cussenot
Olivier Cussenot Université Paris Cité
Rodolfo Montironi
Rodolfo Montironi Marche Polytechnic University
Antonio Lopez-Beltran
Antonio Lopez-Beltran University of Córdoba
Lars Egevad
Lars Egevad Karolinska Institute
Liang Cheng
Liang Cheng Brown University
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna
Daniel M. Berney
Daniel M. Berney Barts Health NHS Trust
Richard Zigeuner
Richard Zigeuner Medical University of Graz
Cristina Magi-Galluzzi
Cristina Magi-Galluzzi University of Alabama at Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring careers related to medicine, there are several online degree options that can lead to rewarding roles in healthcare. Many students consider administrative and patient care pathways that offer flexibility and strong job prospects.

For those interested in managing medical data, an online health information management degree provides specialized training in the organization and protection of patient records. Another growing field is medical billing and coding, where you can quickly learn to process insurance claims and health information. To understand the investment needed, read more about how much is medical billing and coding school.

If patient care is your passion, becoming a nurse practitioner can open many doors. There are options to find some of the cheapest nurse practitioner programs online. Registered nurses looking to expand their credentials can also find the cheapest rn to bsn online programs, making advancement more accessible.

Online health degrees and certifications can be affordable, flexible, and fast, helping you start or advance your medical career while managing other life commitments.

Best Scientists Citing Eva Comperat

Trending Scientists

Recently Published Articles